Kailera Therapeutics

At Kailera, our team’s support for one another and shared determination keep us focused on our goals. It’s the power of teamwork and collaboration that propels us forward. Our #KaiLife this month features Taewon Kang, Director of Device Engineering.    “𝘞𝘩𝘦𝘯 𝘐 𝘫𝘰𝘪𝘯𝘦𝘥 𝘒𝘢𝘪𝘭𝘦𝘳𝘢, 𝘐 𝘸𝘢𝘴 𝘪𝘮𝘮𝘦𝘥𝘪𝘢𝘵𝘦𝘭𝘺 𝘪𝘮𝘱𝘳𝘦𝘴𝘴𝘦𝘥 𝘣𝘺 𝘵𝘩𝘦 𝘮𝘪𝘴𝘴𝘪𝘰𝘯-𝘥𝘳𝘪𝘷𝘦𝘯 𝘢𝘯𝘥 𝙘𝙤𝙡𝙡𝙖𝙗𝙤𝙧𝙖𝙩𝙞𝙫𝙚 𝘤𝘶𝘭𝘵𝘶𝘳𝘦. 𝘛𝘩𝘦 𝘵𝘦𝘢𝘮’𝘴 𝙘𝙤𝙢𝙢𝙞𝙩𝙢𝙚𝙣𝙩 𝘵𝘰 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴 𝘢𝘯𝘥 𝘩𝘦𝘭𝘱𝘪𝘯𝘨 𝘦𝘢𝘤𝘩 𝘰𝘵𝘩𝘦𝘳 𝘴𝘶𝘤𝘤𝘦𝘦𝘥 𝘢𝘭𝘭𝘰𝘸𝘦𝘥 𝘮𝘦 𝘵𝘰 𝘩𝘪𝘵 𝘵𝘩𝘦 𝘨𝘳𝘰𝘶𝘯𝘥 𝘳𝘶𝘯𝘯𝘪𝘯𝘨 𝘸𝘪𝘵𝘩 𝘢 𝘣𝘪𝘨 𝘣𝘰𝘰𝘴𝘵 𝘧𝘳𝘰𝘮 𝘵𝘩𝘦 𝘵𝘦𝘢𝘮 𝘢𝘳𝘰𝘶𝘯𝘥 𝘮𝘦. 𝘞𝘦 𝘢𝘭𝘭 𝘤𝘰𝘯𝘵𝘪𝘯𝘶𝘦 𝘵𝘰 𝘦𝘮𝘱𝘰𝘸𝘦𝘳 𝘦𝘢𝘤𝘩 𝘰𝘵𝘩𝘦𝘳 𝘵𝘰 𝘣𝘦 𝘵𝘩𝘦 𝘣𝘦𝘴𝘵 𝘢𝘯𝘥 𝘵𝘰 𝘴𝘵𝘳𝘪𝘷𝘦 𝘵𝘰 𝘣𝘳𝘪𝘯𝘨 𝘱𝘰𝘵𝘦𝘯𝘵𝘪𝘢𝘭𝘭𝘺 𝘭𝘪𝘧𝘦-𝘤𝘩𝘢𝘯𝘨𝘪𝘯𝘨 𝘵𝘩𝘦𝘳𝘢𝘱𝘪𝘦𝘴 𝘵𝘰 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴.”    Check back for new #KaiLife featuring our amazing #KaiCrew.     #KaileraTx 

In honor of #NationalInternDay, we’re sending a big shoutout to our first-ever intern class at Kailera! These bright minds are making waves, and we couldn’t be prouder of them. Here’s to a summer of learning, growth, and collaboration in support of our mission to empower people to transform their lives!    #NextWave #KaiCrew #KaileraTx 

🌟 𝗖𝗼𝗿𝗲 𝗩𝗮𝗹𝘂𝗲 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: Collaborative 🌟    At the heart of our culture is a commitment to communicating openly and honestly—because growth thrives on trust and transparency. We believe in:   🔹 Elevating others through feedback and cross-functional collaboration  🔹 Building trust with transparency and authenticity  🔹 Stepping in, stepping up, and championing one another as one interconnected team    Together, we grow stronger. Together, we soar.    #KaiValues #Collaborative #KaiCrew #KaileraTx 

🌟 𝗖𝗼𝗿𝗲 𝗩𝗮𝗹𝘂𝗲 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: Courageous🌟    Courage isn’t just bold moves—it’s how we continue to innovate and push boundaries every day! Here’s what being courageous means for the #KaiCrew:  🔹 We respectfully challenge ideas (and each other)  🔹 We think beyond the status quo  🔹 We face challenges head-on    #KaiValues #Courageous #KaileraTx

We’re thrilled to share positive topline data from our partner Hengrui Pharma’s Phase 3 clinical trial in China of dual GLP-1/GIP receptor agonist HRS9531 (being developed globally as KAI-9531) in people living with obesity and overweight. With 19.2% mean weight loss at week 48 at the 6 mg dose and a favorable safety profile consistent with other GLP-1-based treatments, these data affirm our belief in KAI-9531's tremendous potential impact. In our global clinical program, we look forward to evaluating both higher doses and longer duration of treatment to expand on KAI-9531's best-in-class potential for the treatment of obesity.    We commend our colleagues at Hengrui on this impressive data and their commitment to delivering this therapy to improve the lives of people living with obesity or overweight!    Learn more: https://lnkd.in/eCzkZ77W   #KaileraTx #Obesity #GLP1 / Kailera Therapeutics 

Being part of a team that is committed to a common goal is truly invaluable. At Kailera, we are united in our mission to make a meaningful impact on the lives of others. This month, our #KaiLife features Aida Ajaz, Associate Director of Drug Substance Development. “𝘐 𝘫𝘰𝘪𝘯𝘦𝘥 𝘒𝘢𝘪𝘭𝘦𝘳𝘢 𝘵𝘰 𝘣𝘦 𝘱𝘢𝘳𝘵 𝘰𝘧 𝘢 𝘧𝘰𝘤𝘶𝘴𝘦𝘥, 𝘥𝘳𝘪𝘷𝘦𝘯, 𝘢𝘯𝘥 𝘤𝘰𝘭𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘪𝘷𝘦 𝘵𝘦𝘢𝘮. 𝘞𝘦 𝘢𝘳𝘦 𝘶𝘯𝘪𝘵𝘦𝘥 𝘣𝘺 𝘢 𝘤𝘭𝘦𝘢𝘳 𝘢𝘯𝘥 𝘮𝘦𝘢𝘯𝘪𝘯𝘨𝘧𝘶𝘭 𝘮𝘪𝘴𝘴𝘪𝘰𝘯, 𝘢𝘯𝘥 𝘐 𝘢𝘮 𝘦𝘹𝘤𝘪𝘵𝘦𝘥 𝘵𝘰 𝘣𝘦 𝘱𝘢𝘳𝘵 𝘰𝘧 𝘢 𝘵𝘦𝘢𝘮 𝘸𝘩𝘦𝘳𝘦 𝘐 𝘤𝘢𝘯 𝘨𝘳𝘰𝘸 𝘱𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭𝘭𝘺 𝘢𝘯𝘥 𝘤𝘰𝘯𝘵𝘳𝘪𝘣𝘶𝘵𝘦 𝘵𝘰 𝘒𝘢𝘪𝘭𝘦𝘳𝘢’𝘴 𝘴𝘶𝘤𝘤𝘦𝘴𝘴.” Be on the lookout for more #KaiLife stories from our #KaiCrew! #KaileraTx

🎉 We’re excited to share that thanks to the time and effort of a cross-functional group, and with input from the entire #KaiCrew, we’ve defined our core values — Courageous, Collaborative, Compassionate, and Committed. Unique to Kailera and thoughtfully crafted by our team, these values describe how we show up for one another every day and get to the heart and soul of what matters most to us. We’re excited to look to these values to guide our mission and shape our day-to-day life at Kailera!    ✨Stay tuned to learn more about each value over the next few weeks!    #KaiValues #KaileraTx 

At Kailera, our team is built on collaboration and commitment. Reaching our goals takes a team that sees beyond the data and understands the real impact of their work. This #KaiLeaders spotlight features Jianfei Jiang, Director of Statistical Programming.  “𝘔𝘺 𝘪𝘯𝘵𝘦𝘳𝘥𝘪𝘴𝘤𝘪𝘱𝘭𝘪𝘯𝘢𝘳𝘺 𝘣𝘢𝘤𝘬𝘨𝘳𝘰𝘶𝘯𝘥 𝘪𝘯 𝘣𝘪𝘰𝘴𝘵𝘢𝘵𝘪𝘴𝘵𝘪𝘤𝘴 𝘢𝘯𝘥 𝘱𝘩𝘢𝘳𝘮𝘢𝘤𝘰𝘭𝘰𝘨𝘺 𝘥𝘳𝘪𝘷𝘦𝘴 𝘮𝘺 𝘥𝘦𝘦𝘱 𝘤𝘰𝘮𝘮𝘪𝘵𝘮𝘦𝘯𝘵 𝘵𝘰 𝘭𝘦𝘷𝘦𝘳𝘢𝘨𝘪𝘯𝘨 𝘥𝘢𝘵𝘢-𝘥𝘳𝘪𝘷𝘦𝘯 𝘪𝘯𝘴𝘪𝘨𝘩𝘵𝘴 𝘵𝘰 𝘮𝘢𝘬𝘦 𝘢 𝘵𝘢𝘯𝘨𝘪𝘣𝘭𝘦 𝘥𝘪𝘧𝘧𝘦𝘳𝘦𝘯𝘤𝘦 𝘪𝘯 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦, 𝘧𝘳𝘰𝘮 𝘪𝘮𝘮𝘶𝘯𝘰𝘭𝘰𝘨𝘺 𝘵𝘰 𝘰𝘯𝘤𝘰𝘭𝘰𝘨𝘺 𝘢𝘯𝘥 𝘮𝘦𝘵𝘢𝘣𝘰𝘭𝘪𝘤 𝘥𝘪𝘴𝘦𝘢𝘴𝘦𝘴. 𝘈𝘵 𝘒𝘢𝘪𝘭𝘦𝘳𝘢, 𝘐 𝘰𝘷𝘦𝘳𝘴𝘦𝘦 𝘵𝘩𝘦 𝘴𝘵𝘳𝘢𝘵𝘦𝘨𝘪𝘤 𝘥𝘪𝘳𝘦𝘤𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘰𝘱𝘦𝘳𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘦𝘹𝘦𝘤𝘶𝘵𝘪𝘰𝘯 𝘰𝘧 𝘰𝘶𝘳 𝘴𝘵𝘢𝘵𝘪𝘴𝘵𝘪𝘤𝘢𝘭 𝘱𝘳𝘰𝘨𝘳𝘢𝘮𝘮𝘪𝘯𝘨 𝘢𝘤𝘵𝘪𝘷𝘪𝘵𝘪𝘦𝘴. 𝘔𝘺 𝘧𝘰𝘤𝘶𝘴 𝘦𝘹𝘵𝘦𝘯𝘥𝘴 𝘣𝘦𝘺𝘰𝘯𝘥 𝘵𝘩𝘦 𝘵𝘪𝘮𝘦𝘭𝘺 𝘢𝘯𝘥 𝘢𝘤𝘤𝘶𝘳𝘢𝘵𝘦 𝘥𝘦𝘭𝘪𝘷𝘦𝘳𝘺 𝘰𝘧 𝘢𝘯𝘢𝘭𝘺𝘴𝘪𝘴-𝘳𝘦𝘢𝘥𝘺 𝘥𝘢𝘵𝘢, 𝘴𝘵𝘢𝘵𝘪𝘴𝘵𝘪𝘤𝘢𝘭 𝘰𝘶𝘵𝘱𝘶𝘵𝘴, 𝘢𝘯𝘥 𝘳𝘦𝘨𝘶𝘭𝘢𝘵𝘰𝘳𝘺 𝘥𝘰𝘤𝘶𝘮𝘦𝘯𝘵𝘢𝘵𝘪𝘰𝘯. 𝘐𝘯 𝘧𝘢𝘤𝘵, 𝘢 𝘤𝘰𝘳𝘦 𝘢𝘴𝘱𝘦𝘤𝘵 𝘰𝘧 𝘮𝘺 𝘭𝘦𝘢𝘥𝘦𝘳𝘴𝘩𝘪𝘱 𝘪𝘯𝘷𝘰𝘭𝘷𝘦𝘴 𝘨𝘶𝘪𝘥𝘪𝘯𝘨 𝘰𝘶𝘳 𝘵𝘢𝘭𝘦𝘯𝘵𝘦𝘥 𝘵𝘦𝘢𝘮 𝘵𝘰 𝘣𝘦𝘤𝘰𝘮𝘦 𝘵𝘳𝘶𝘦 "𝘥𝘢𝘵𝘢 𝘥𝘦𝘵𝘦𝘤𝘵𝘪𝘷𝘦𝘴" – 𝘶𝘯𝘥𝘦𝘳𝘴𝘵𝘢𝘯𝘥𝘪𝘯𝘨 𝘵𝘩𝘦 𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘤𝘰𝘯𝘵𝘦𝘹𝘵, 𝘦𝘹𝘱𝘭𝘰𝘳𝘪𝘯𝘨 𝘵𝘩𝘦 𝘴𝘵𝘰𝘳𝘺 𝘵𝘩𝘦 𝘥𝘢𝘵𝘢 𝘵𝘦𝘭𝘭𝘴, 𝘢𝘯𝘥 𝘦𝘧𝘧𝘦𝘤𝘵𝘪𝘷𝘦𝘭𝘺 𝘤𝘰𝘮𝘮𝘶𝘯𝘪𝘤𝘢𝘵𝘪𝘯𝘨 𝘵𝘩𝘰𝘴𝘦 𝘤𝘳𝘶𝘤𝘪𝘢𝘭 𝘪𝘯𝘴𝘪𝘨𝘩𝘵𝘴 𝘵𝘰 𝘴𝘵𝘢𝘬𝘦𝘩𝘰𝘭𝘥𝘦𝘳𝘴. 𝘛𝘩𝘪𝘴 𝘶𝘯𝘥𝘦𝘳𝘴𝘵𝘢𝘯𝘥𝘪𝘯𝘨 𝘪𝘴 𝘷𝘪𝘵𝘢𝘭 𝘧𝘰𝘳 𝘪𝘯𝘧𝘰𝘳𝘮𝘦𝘥 𝘥𝘦𝘤𝘪𝘴𝘪𝘰𝘯-𝘮𝘢𝘬𝘪𝘯𝘨 𝘵𝘩𝘢𝘵 𝘶𝘭𝘵𝘪𝘮𝘢𝘵𝘦𝘭𝘺 𝘴𝘩𝘢𝘱𝘦𝘴 𝘵𝘩𝘦 𝘪𝘮𝘱𝘢𝘤𝘵 𝘰𝘧 𝘰𝘶𝘳 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘷𝘦 𝘮𝘦𝘥𝘪𝘤𝘪𝘯𝘦𝘴 𝘰𝘯 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴 𝘢𝘯𝘥 𝘤𝘰𝘯𝘵𝘳𝘪𝘣𝘶𝘵𝘦𝘴 𝘵𝘰 𝘒𝘢𝘪𝘭𝘦𝘳𝘢'𝘴 𝘨𝘳𝘰𝘸𝘵𝘩. 𝘈𝘴 𝘸𝘦 𝘣𝘶𝘪𝘭𝘥 𝘵𝘰𝘸𝘢𝘳𝘥𝘴 𝘵𝘩𝘦 ��𝘶𝘵𝘶𝘳𝘦 𝘸𝘪𝘵𝘩 𝘢𝘯 𝘦𝘹𝘤𝘪𝘵𝘪𝘯𝘨 𝘢𝘯𝘥 𝘨𝘳𝘰𝘸𝘪𝘯𝘨 𝘱𝘪𝘱𝘦𝘭𝘪𝘯𝘦, 𝘸𝘦’𝘳𝘦 𝘴𝘦𝘦𝘬𝘪𝘯𝘨 𝘱𝘢𝘴𝘴𝘪𝘰𝘯𝘢𝘵𝘦 𝘴𝘵𝘢𝘵𝘪𝘴𝘵𝘪𝘤𝘢𝘭 𝘱𝘳𝘰𝘨𝘳𝘢𝘮𝘮𝘪𝘯𝘨 𝘱𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭𝘴 𝘵𝘰 𝘫𝘰𝘪𝘯 𝘶𝘴. 𝘏𝘦𝘳𝘦, 𝘺𝘰𝘶'𝘭𝘭 𝘩𝘢𝘷𝘦 𝘵𝘩𝘦 𝘰𝘱𝘱𝘰𝘳𝘵𝘶𝘯𝘪𝘵𝘺 𝘵𝘰 𝘴𝘩𝘢𝘱𝘦 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘷𝘦 𝘴𝘵𝘢𝘵𝘪𝘴𝘵𝘪𝘤𝘢𝘭 𝘴𝘵𝘳𝘢𝘵𝘦𝘨𝘪𝘦𝘴 𝘵𝘩𝘢𝘵 𝘥𝘪𝘳𝘦𝘤𝘵𝘭𝘺 𝘴𝘶𝘱𝘱𝘰𝘳𝘵 𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘥𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵 𝘢𝘯𝘥 𝘤𝘰𝘳𝘱𝘰𝘳𝘢𝘵𝘦 𝘨𝘳𝘰𝘸𝘵𝘩, 𝘢𝘭𝘭 𝘸𝘪𝘵𝘩𝘪𝘯 𝘢 𝘱𝘰𝘴𝘪𝘵𝘪𝘷𝘦, 𝘧𝘶𝘯, 𝘢𝘯𝘥 𝘤𝘰𝘭𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘪𝘷𝘦 𝘦𝘯𝘷𝘪𝘳𝘰𝘯𝘮𝘦𝘯𝘵. 𝘓𝘦𝘵'𝘴 𝘤𝘰𝘯𝘯𝘦𝘤𝘵 𝘢𝘯𝘥 𝘣𝘶𝘪𝘭𝘥 𝘴𝘰𝘮𝘦𝘵𝘩𝘪𝘯𝘨 𝘢𝘮𝘢𝘻𝘪𝘯𝘨!” Keep an eye out for more #KaiLeaders spotlights to meet more of the minds behind our mission. #KaiCrew #KaileraTx  

The Kailera Therapeutics team is thrilled to join our partner Hengrui Pharma Co.,Ltd at #ADA2025! We’re looking forward to a great weekend gathering with clinicians, researchers, and experts to hear and discuss the latest findings in obesity and diabetes research, prevention, and care.   Learn more: https://lnkd.in/esycMYaM    #ADASciSessions #ADA #KaiCrew #KaileraTx  American Diabetes Association

We were fortunate to have Joe Nadglowski, President and CEO of the Obesity Action Coalition join us for a weight bias training session aimed at deepening our understanding of weight bias and its connection to the work we do at Kailera.     This information will help us to deliver on our mission to develop therapies that empower people to live their lives to the fullest. Thank you to OAC for helping us better recognize and address weight bias - the first step in challenging it and advocating for more inclusive and equitable environments.       #KaiCrew #KaileraTx #Obesity